Summit Therapeutics shares owned by Mercer Global Advisors
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Mercer Global Advisors
from 13F filings
Historical chart of Mercer Global Advisors investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Mercer Global Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $204k | 49k | 4.15 |
| 2023-12-31 | $126k | 48k | 2.61 |
| 2023-09-30 | $90k | 48k | 1.86 |
| 2023-06-30 | $121k | 48k | 2.51 |
| 2023-03-31 | $75k | 43k | 1.74 |
| 2022-12-31 | $183k | 43k | 4.25 |
| 2022-09-30 | $50k | 42k | 1.18 |
| 2022-06-30 | $40k | 40k | 1.00 |
| 2022-03-31 | $61k | 25k | 2.45 |
| 2021-12-31 | $59k | 22k | 2.69 |
| 2021-09-30 | $90k | 18k | 5.01 |
| 2021-06-30 | $134k | 18k | 7.47 |
| 2021-03-31 | $99k | 17k | 5.84 |